QV Bioelectronics

QV Bioelectronics is developing a medical device that will extend the lives of people with terminal brain cancer (glioblastoma). It was founded by Dr. Chris Bullock and Dr. Richard Fu and they are based at Alderley Park. They are producing a working prototype of their implant and are in the process of executing their development strategy towards a first-in-man clinical trial.

Why we like the business

Glioblastoma is one of the most aggressive cancers yet there have been precious few treatment innovations over the decades. We invested in QV Bioelectronics because they bring together Manchester’s leadership position in advanced materials with the know-how of some of the UK’s most pre-eminent neurosurgeons to reimagine the use of electrotherapy – a new modality to treat cancer - in a way that will turn the tide on this devastating disease.